 Barry Rumack
Concepts (688)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetaminophen | 67 | 2025 | 264 | 8.800 |
Why?
| | Analgesics, Non-Narcotic | 21 | 2025 | 123 | 5.950 |
Why?
| | Chemical and Drug Induced Liver Injury | 31 | 2024 | 139 | 5.080 |
Why?
| | Acetylcysteine | 35 | 2024 | 139 | 4.290 |
Why?
| | Drug Overdose | 27 | 2025 | 370 | 3.830 |
Why?
| | Antidotes | 24 | 2024 | 145 | 2.680 |
Why?
| | Poisoning | 25 | 2012 | 119 | 1.130 |
Why?
| | Nomograms | 4 | 2019 | 59 | 1.000 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2023 | 257 | 0.820 |
Why?
| | Antiemetics | 1 | 2024 | 49 | 0.790 |
Why?
| | Poison Control Centers | 17 | 2025 | 84 | 0.780 |
Why?
| | Poisons | 1 | 2023 | 20 | 0.780 |
Why?
| | Canada | 6 | 2025 | 428 | 0.700 |
Why?
| | Alanine Transaminase | 8 | 2022 | 151 | 0.690 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 94 | 0.600 |
Why?
| | Liver | 23 | 2023 | 1887 | 0.550 |
Why?
| | Humans | 203 | 2025 | 144759 | 0.510 |
Why?
| | Anaphylaxis | 1 | 2018 | 102 | 0.490 |
Why?
| | Cyanides | 9 | 1993 | 56 | 0.480 |
Why?
| | Decision Support Techniques | 1 | 2019 | 456 | 0.420 |
Why?
| | Nonprescription Drugs | 4 | 2008 | 65 | 0.420 |
Why?
| | Free Radical Scavengers | 2 | 2012 | 82 | 0.380 |
Why?
| | Sodium Nitrite | 7 | 1997 | 39 | 0.380 |
Why?
| | Mushroom Poisoning | 4 | 2019 | 5 | 0.370 |
Why?
| | Charcoal | 12 | 1999 | 27 | 0.370 |
Why?
| | Medication Errors | 1 | 2012 | 83 | 0.340 |
Why?
| | Plant Poisoning | 6 | 1988 | 8 | 0.340 |
Why?
| | Iatrogenic Disease | 1 | 2012 | 76 | 0.340 |
Why?
| | Adult | 72 | 2023 | 40449 | 0.310 |
Why?
| | Retrospective Studies | 14 | 2023 | 17066 | 0.300 |
Why?
| | Adolescent | 43 | 2020 | 22428 | 0.300 |
Why?
| | Protective Agents | 2 | 2020 | 42 | 0.300 |
Why?
| | Nasal Decongestants | 1 | 2008 | 8 | 0.290 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2023 | 30 | 0.290 |
Why?
| | Antitussive Agents | 1 | 2008 | 7 | 0.290 |
Why?
| | Environmental Exposure | 7 | 2012 | 588 | 0.290 |
Why?
| | Common Cold | 1 | 2008 | 15 | 0.290 |
Why?
| | Male | 86 | 2022 | 72315 | 0.280 |
Why?
| | Nitrites | 5 | 1989 | 89 | 0.280 |
Why?
| | Multicenter Studies as Topic | 3 | 2024 | 405 | 0.280 |
Why?
| | Time Factors | 21 | 2021 | 7173 | 0.270 |
Why?
| | Cough | 1 | 2008 | 124 | 0.270 |
Why?
| | Alcohol Drinking | 2 | 2012 | 826 | 0.250 |
Why?
| | Hyperbaric Oxygenation | 5 | 1991 | 39 | 0.250 |
Why?
| | Hepatocytes | 4 | 2022 | 223 | 0.240 |
Why?
| | Hydrogen Sulfide | 3 | 1997 | 48 | 0.240 |
Why?
| | Child | 42 | 2023 | 22633 | 0.230 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 3 | 2020 | 153 | 0.220 |
Why?
| | Administration, Oral | 11 | 2019 | 847 | 0.220 |
Why?
| | Pain | 2 | 2020 | 779 | 0.220 |
Why?
| | Female | 73 | 2022 | 78271 | 0.210 |
Why?
| | Ibuprofen | 3 | 1992 | 84 | 0.210 |
Why?
| | Infant | 36 | 2012 | 10034 | 0.210 |
Why?
| | Potassium Cyanide | 3 | 1989 | 22 | 0.210 |
Why?
| | Infusions, Intravenous | 5 | 2019 | 423 | 0.210 |
Why?
| | Ethanol | 9 | 2012 | 627 | 0.210 |
Why?
| | Databases, Factual | 6 | 2019 | 1486 | 0.210 |
Why?
| | Child, Preschool | 38 | 2014 | 11787 | 0.210 |
Why?
| | Plants, Medicinal | 3 | 1989 | 23 | 0.200 |
Why?
| | Drug Information Services | 6 | 1988 | 10 | 0.200 |
Why?
| | Risk Assessment | 3 | 2024 | 3671 | 0.200 |
Why?
| | Young Adult | 9 | 2023 | 14105 | 0.200 |
Why?
| | Liver Failure, Acute | 1 | 2024 | 67 | 0.200 |
Why?
| | Aspirin | 8 | 1989 | 399 | 0.190 |
Why?
| | Imines | 1 | 2022 | 6 | 0.190 |
Why?
| | Free Radicals | 2 | 1993 | 110 | 0.190 |
Why?
| | Triage | 1 | 2025 | 249 | 0.180 |
Why?
| | Alcoholism | 5 | 2000 | 817 | 0.180 |
Why?
| | Benzoquinones | 1 | 2022 | 47 | 0.180 |
Why?
| | Salicylates | 7 | 1989 | 29 | 0.180 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 1992 | 19 | 0.170 |
Why?
| | Ipecac | 6 | 1990 | 8 | 0.170 |
Why?
| | Suicide, Attempted | 12 | 1990 | 422 | 0.170 |
Why?
| | Thiosulfates | 4 | 1993 | 19 | 0.170 |
Why?
| | Liver Function Tests | 3 | 2012 | 106 | 0.170 |
Why?
| | Physostigmine | 6 | 1983 | 13 | 0.160 |
Why?
| | Hypotension | 5 | 1989 | 126 | 0.160 |
Why?
| | Coma | 9 | 1990 | 37 | 0.160 |
Why?
| | United States | 16 | 2025 | 15966 | 0.160 |
Why?
| | Cytochrome P-450 CYP2E1 Inhibitors | 1 | 2019 | 2 | 0.160 |
Why?
| | Time-to-Treatment | 2 | 2019 | 243 | 0.150 |
Why?
| | Emergencies | 6 | 1989 | 175 | 0.150 |
Why?
| | Seizures | 6 | 1991 | 460 | 0.150 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 732 | 0.150 |
Why?
| | Electric Power Supplies | 3 | 1992 | 52 | 0.150 |
Why?
| | Acute Kidney Injury | 4 | 2020 | 865 | 0.150 |
Why?
| | Agaricales | 1 | 2018 | 3 | 0.150 |
Why?
| | Smoke Inhalation Injury | 2 | 1989 | 30 | 0.140 |
Why?
| | Emergency Medical Services | 2 | 2025 | 696 | 0.140 |
Why?
| | Metabolome | 1 | 2022 | 384 | 0.140 |
Why?
| | Fever | 2 | 2000 | 311 | 0.140 |
Why?
| | Emetics | 5 | 1984 | 7 | 0.140 |
Why?
| | Magnesium | 3 | 1988 | 155 | 0.140 |
Why?
| | Ambulatory Care | 1 | 2023 | 600 | 0.140 |
Why?
| | Foreign Bodies | 3 | 1992 | 107 | 0.140 |
Why?
| | Administration, Intravenous | 2 | 2016 | 170 | 0.140 |
Why?
| | Excipients | 2 | 1988 | 54 | 0.140 |
Why?
| | Histamine Antagonists | 1 | 2018 | 20 | 0.140 |
Why?
| | Cathartics | 4 | 1992 | 15 | 0.130 |
Why?
| | Information Systems | 4 | 2010 | 57 | 0.130 |
Why?
| | Dermatitis, Contact | 2 | 1989 | 18 | 0.130 |
Why?
| | Prothrombin Time | 3 | 1993 | 33 | 0.130 |
Why?
| | Glutathione | 5 | 2022 | 375 | 0.130 |
Why?
| | Sex Factors | 5 | 2022 | 2112 | 0.130 |
Why?
| | Phenytoin | 3 | 2004 | 21 | 0.120 |
Why?
| | Occupational Diseases | 2 | 1990 | 165 | 0.120 |
Why?
| | Hospital Mortality | 1 | 2021 | 1030 | 0.120 |
Why?
| | Hospitals | 1 | 2021 | 730 | 0.120 |
Why?
| | Drug Monitoring | 1 | 1999 | 395 | 0.120 |
Why?
| | Drug Interactions | 4 | 2019 | 398 | 0.120 |
Why?
| | Amygdalin | 3 | 1986 | 3 | 0.110 |
Why?
| | Middle Aged | 22 | 2023 | 35875 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 359 | 0.110 |
Why?
| | Cimetidine | 1 | 1995 | 11 | 0.110 |
Why?
| | Animals | 25 | 2024 | 38058 | 0.110 |
Why?
| | Toxicology | 3 | 1990 | 49 | 0.110 |
Why?
| | 3,4-Methylenedioxyamphetamine | 2 | 1987 | 2 | 0.110 |
Why?
| | Amphetamines | 2 | 1987 | 6 | 0.110 |
Why?
| | Patient Selection | 1 | 2019 | 719 | 0.110 |
Why?
| | Arsenic Poisoning | 2 | 1989 | 7 | 0.110 |
Why?
| | Drug Administration Schedule | 4 | 2014 | 779 | 0.110 |
Why?
| | Aspartate Aminotransferases | 6 | 2002 | 85 | 0.100 |
Why?
| | Riots | 1 | 1993 | 2 | 0.100 |
Why?
| | Psychophysiologic Disorders | 1 | 1993 | 10 | 0.100 |
Why?
| | Societies | 5 | 2012 | 40 | 0.100 |
Why?
| | Risk | 5 | 2009 | 911 | 0.100 |
Why?
| | Cohort Studies | 2 | 2018 | 5960 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2115 | 0.100 |
Why?
| | Acute Disease | 8 | 1993 | 1030 | 0.100 |
Why?
| | Hydrocarbons, Halogenated | 1 | 1993 | 5 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2018 | 11679 | 0.100 |
Why?
| | Methemoglobin | 3 | 1989 | 24 | 0.100 |
Why?
| | Carbon Tetrachloride | 1 | 1993 | 13 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 969 | 0.090 |
Why?
| | Mice, Inbred C57BL | 5 | 2023 | 5992 | 0.090 |
Why?
| | Risk Factors | 4 | 2019 | 10779 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2925 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 32 | 0.090 |
Why?
| | Phenobarbital | 4 | 2004 | 19 | 0.090 |
Why?
| | United States Food and Drug Administration | 2 | 2012 | 203 | 0.090 |
Why?
| | Electrolytes | 2 | 1990 | 55 | 0.090 |
Why?
| | Life Change Events | 1 | 1993 | 147 | 0.090 |
Why?
| | Digestive System | 1 | 1992 | 28 | 0.090 |
Why?
| | Prospective Studies | 11 | 2020 | 7990 | 0.090 |
Why?
| | Hydrocarbons | 2 | 1986 | 31 | 0.090 |
Why?
| | Vascular Headaches | 1 | 1991 | 1 | 0.090 |
Why?
| | Drug Dosage Calculations | 1 | 2012 | 27 | 0.090 |
Why?
| | Fluoride Poisoning | 1 | 1991 | 3 | 0.090 |
Why?
| | Warfarin | 1 | 1993 | 170 | 0.090 |
Why?
| | Sympathomimetics | 1 | 1991 | 19 | 0.090 |
Why?
| | Bromocriptine | 1 | 1991 | 31 | 0.090 |
Why?
| | Carbon Tetrachloride Poisoning | 1 | 1991 | 2 | 0.090 |
Why?
| | Prognosis | 3 | 2019 | 4282 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2363 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1985 | 0.090 |
Why?
| | Gas Poisoning | 2 | 1993 | 4 | 0.090 |
Why?
| | Magnesium Sulfate | 2 | 1988 | 18 | 0.090 |
Why?
| | Methemoglobinemia | 3 | 1986 | 13 | 0.080 |
Why?
| | Hydroxocobalamin | 2 | 1993 | 33 | 0.080 |
Why?
| | Vancomycin | 1 | 1992 | 93 | 0.080 |
Why?
| | Half-Life | 8 | 1992 | 151 | 0.080 |
Why?
| | Methanol | 1 | 1991 | 46 | 0.080 |
Why?
| | Information Services | 3 | 1990 | 46 | 0.080 |
Why?
| | Kinetics | 13 | 1987 | 1627 | 0.080 |
Why?
| | Gastric Lavage | 6 | 1992 | 9 | 0.080 |
Why?
| | Incidence | 1 | 2018 | 2879 | 0.080 |
Why?
| | Sulfates | 1 | 1990 | 49 | 0.080 |
Why?
| | Pyridoxine | 1 | 1990 | 37 | 0.080 |
Why?
| | Therapeutic Irrigation | 1 | 1990 | 69 | 0.080 |
Why?
| | Amphotericin B | 1 | 1990 | 37 | 0.080 |
Why?
| | Interior Design and Furnishings | 1 | 1990 | 5 | 0.080 |
Why?
| | Methylene Chloride | 1 | 1990 | 5 | 0.080 |
Why?
| | Hydrofluoric Acid | 2 | 1989 | 7 | 0.080 |
Why?
| | Facility Design and Construction | 1 | 1990 | 12 | 0.080 |
Why?
| | Societies, Scientific | 1 | 1990 | 49 | 0.080 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 1990 | 23 | 0.080 |
Why?
| | Alcoholic Intoxication | 2 | 1988 | 74 | 0.080 |
Why?
| | Phenelzine | 2 | 1987 | 4 | 0.080 |
Why?
| | Isoniazid | 1 | 1990 | 71 | 0.080 |
Why?
| | Rodenticides | 1 | 1989 | 3 | 0.080 |
Why?
| | Liver Diseases | 4 | 2002 | 304 | 0.080 |
Why?
| | 4-Hydroxycoumarins | 1 | 1989 | 3 | 0.080 |
Why?
| | Naloxone | 4 | 1985 | 132 | 0.080 |
Why?
| | Penicillamine | 5 | 1986 | 18 | 0.080 |
Why?
| | Plants, Toxic | 2 | 1987 | 18 | 0.080 |
Why?
| | Eucalyptus | 1 | 1989 | 5 | 0.070 |
Why?
| | Sodium Compounds | 1 | 1989 | 5 | 0.070 |
Why?
| | Arsenites | 1 | 1989 | 6 | 0.070 |
Why?
| | Substance-Related Disorders | 4 | 1987 | 1094 | 0.070 |
Why?
| | Mycoses | 1 | 1990 | 88 | 0.070 |
Why?
| | Pregnancy Complications | 2 | 1989 | 592 | 0.070 |
Why?
| | Plant Oils | 1 | 1989 | 31 | 0.070 |
Why?
| | Thyroxine | 2 | 1987 | 64 | 0.070 |
Why?
| | Chlorambucil | 1 | 1988 | 10 | 0.070 |
Why?
| | Trees | 1 | 1989 | 67 | 0.070 |
Why?
| | Antioxidants | 2 | 1993 | 549 | 0.070 |
Why?
| | Writing | 1 | 1990 | 100 | 0.070 |
Why?
| | Construction Materials | 2 | 1986 | 18 | 0.070 |
Why?
| | Alprazolam | 1 | 1988 | 6 | 0.070 |
Why?
| | Captopril | 1 | 1988 | 11 | 0.070 |
Why?
| | Botany | 1 | 1988 | 2 | 0.070 |
Why?
| | Perfume | 1 | 1988 | 5 | 0.070 |
Why?
| | Hospitalization | 2 | 2019 | 2433 | 0.070 |
Why?
| | Iron | 1 | 1991 | 359 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3409 | 0.070 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 81 | 0.070 |
Why?
| | Chewing Gum | 1 | 1988 | 8 | 0.070 |
Why?
| | Heart Diseases | 1 | 1991 | 349 | 0.070 |
Why?
| | Vomiting | 3 | 1988 | 130 | 0.070 |
Why?
| | Fabaceae | 1 | 1988 | 11 | 0.070 |
Why?
| | Diflunisal | 1 | 1987 | 2 | 0.070 |
Why?
| | Critical Pathways | 1 | 2009 | 108 | 0.070 |
Why?
| | Polyethylene Glycols | 2 | 1990 | 654 | 0.070 |
Why?
| | Sweetening Agents | 1 | 1988 | 57 | 0.070 |
Why?
| | Theophylline | 1 | 1987 | 41 | 0.070 |
Why?
| | Zinc | 1 | 1990 | 295 | 0.070 |
Why?
| | Imipramine | 3 | 1979 | 11 | 0.070 |
Why?
| | International System of Units | 1 | 1987 | 2 | 0.060 |
Why?
| | Medication Systems | 1 | 1987 | 3 | 0.060 |
Why?
| | Fruit | 1 | 1988 | 152 | 0.060 |
Why?
| | Weights and Measures | 1 | 1987 | 7 | 0.060 |
Why?
| | Intestinal Absorption | 3 | 1999 | 103 | 0.060 |
Why?
| | Blood Coagulation Disorders | 1 | 1989 | 189 | 0.060 |
Why?
| | Basidiomycota | 1 | 1987 | 27 | 0.060 |
Why?
| | Drug Therapy, Combination | 3 | 2002 | 1047 | 0.060 |
Why?
| | Quinine | 1 | 1987 | 21 | 0.060 |
Why?
| | Mistletoe | 1 | 1986 | 1 | 0.060 |
Why?
| | Pharmacy Service, Hospital | 1 | 1988 | 81 | 0.060 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 1987 | 31 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 3 | 1981 | 361 | 0.060 |
Why?
| | Clonidine | 2 | 1983 | 33 | 0.060 |
Why?
| | Blindness | 1 | 1987 | 52 | 0.060 |
Why?
| | Thiazines | 1 | 1986 | 13 | 0.060 |
Why?
| | Magnesium Compounds | 1 | 1986 | 1 | 0.060 |
Why?
| | Aluminum Compounds | 1 | 1986 | 6 | 0.060 |
Why?
| | Xylazine | 1 | 1986 | 15 | 0.060 |
Why?
| | Boric Acids | 1 | 1986 | 2 | 0.060 |
Why?
| | Silicates | 1 | 1986 | 18 | 0.060 |
Why?
| | Microsomes, Liver | 4 | 1976 | 85 | 0.060 |
Why?
| | Epinephrine | 1 | 1987 | 155 | 0.060 |
Why?
| | Atropine | 4 | 1987 | 37 | 0.060 |
Why?
| | Population Surveillance | 4 | 2011 | 485 | 0.060 |
Why?
| | Aged | 8 | 2020 | 25913 | 0.060 |
Why?
| | Oxidoreductases | 3 | 1986 | 96 | 0.060 |
Why?
| | Yohimbine | 1 | 1985 | 11 | 0.060 |
Why?
| | Bronchodilator Agents | 1 | 1987 | 182 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1720 | 0.060 |
Why?
| | Guanabenz | 1 | 1985 | 1 | 0.060 |
Why?
| | Amitriptyline | 3 | 1983 | 24 | 0.060 |
Why?
| | Guanidines | 1 | 1985 | 41 | 0.060 |
Why?
| | Accidents, Home | 5 | 1988 | 33 | 0.060 |
Why?
| | Gastric Emptying | 1 | 1985 | 36 | 0.060 |
Why?
| | Infant, Newborn | 8 | 2008 | 6429 | 0.060 |
Why?
| | Injections, Intravenous | 4 | 1991 | 200 | 0.060 |
Why?
| | Chlorobenzenes | 1 | 1985 | 19 | 0.060 |
Why?
| | Pancreatitis | 1 | 1986 | 145 | 0.060 |
Why?
| | Marine Toxins | 1 | 1985 | 12 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 3 | 1985 | 186 | 0.060 |
Why?
| | Nicotine | 1 | 1988 | 331 | 0.050 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 1993 | 893 | 0.050 |
Why?
| | Kidney | 3 | 2023 | 1495 | 0.050 |
Why?
| | Naphthalenes | 1 | 1985 | 56 | 0.050 |
Why?
| | Insecticides | 1 | 1985 | 42 | 0.050 |
Why?
| | Morphinans | 3 | 1973 | 8 | 0.050 |
Why?
| | Lactones | 1 | 1985 | 58 | 0.050 |
Why?
| | Computers | 2 | 1988 | 67 | 0.050 |
Why?
| | Bacterial Toxins | 1 | 1985 | 109 | 0.050 |
Why?
| | Mice | 4 | 2023 | 18339 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2014 | 2027 | 0.050 |
Why?
| | Heroin | 1 | 1984 | 29 | 0.050 |
Why?
| | Cyanobacteria | 1 | 1985 | 55 | 0.050 |
Why?
| | Medical History Taking | 2 | 1999 | 117 | 0.050 |
Why?
| | Deglutition | 1 | 1984 | 72 | 0.050 |
Why?
| | Household Products | 1 | 1983 | 6 | 0.050 |
Why?
| | Ethylene Glycols | 1 | 1983 | 17 | 0.050 |
Why?
| | Copper | 1 | 1984 | 113 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 329 | 0.050 |
Why?
| | Cognition Disorders | 1 | 1987 | 538 | 0.050 |
Why?
| | Online Systems | 1 | 1983 | 21 | 0.050 |
Why?
| | Drug Labeling | 2 | 2000 | 37 | 0.050 |
Why?
| | Barbiturates | 2 | 2002 | 6 | 0.050 |
Why?
| | Talc | 1 | 1982 | 9 | 0.050 |
Why?
| | Oxidation-Reduction | 2 | 2019 | 1087 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 488 | 0.050 |
Why?
| | Infant Care | 1 | 1982 | 44 | 0.050 |
Why?
| | Hallucinations | 4 | 1979 | 31 | 0.050 |
Why?
| | Lactates | 1 | 2022 | 83 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 1984 | 170 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2002 | 88 | 0.040 |
Why?
| | Phenylpropanolamine | 3 | 1982 | 3 | 0.040 |
Why?
| | Transaminases | 2 | 2014 | 22 | 0.040 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 112 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2002 | 55 | 0.040 |
Why?
| | Phencyclidine Abuse | 1 | 1980 | 1 | 0.040 |
Why?
| | Hemorrhage | 1 | 1986 | 809 | 0.040 |
Why?
| | Colorado | 7 | 1992 | 4564 | 0.040 |
Why?
| | Stomach | 4 | 1988 | 109 | 0.040 |
Why?
| | Fluid Therapy | 3 | 1988 | 147 | 0.040 |
Why?
| | Pharmacology | 1 | 2000 | 11 | 0.040 |
Why?
| | Activation, Metabolic | 1 | 2019 | 5 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 5868 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2002 | 235 | 0.040 |
Why?
| | Methapyrilene | 1 | 1979 | 1 | 0.040 |
Why?
| | Salicylamides | 1 | 1979 | 3 | 0.040 |
Why?
| | Immune System | 1 | 2020 | 179 | 0.040 |
Why?
| | Psychology, Child | 1 | 1979 | 37 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 124 | 0.040 |
Why?
| | Drug Compounding | 1 | 1999 | 107 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2000 | 1053 | 0.040 |
Why?
| | Digoxin | 2 | 1979 | 27 | 0.040 |
Why?
| | Pediatrics | 1 | 1987 | 1114 | 0.040 |
Why?
| | Age Factors | 4 | 1999 | 3333 | 0.030 |
Why?
| | Evaluation Studies as Topic | 4 | 1988 | 166 | 0.030 |
Why?
| | Aminopyridines | 1 | 1979 | 127 | 0.030 |
Why?
| | Infant, Newborn, Diseases | 2 | 1981 | 113 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2019 | 601 | 0.030 |
Why?
| | Lipids | 1 | 2022 | 710 | 0.030 |
Why?
| | Caustics | 1 | 1977 | 6 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 984 | 0.030 |
Why?
| | Child Behavior | 1 | 1979 | 236 | 0.030 |
Why?
| | Critical Care | 1 | 1983 | 695 | 0.030 |
Why?
| | Metabolic Clearance Rate | 2 | 1987 | 114 | 0.030 |
Why?
| | Heart Arrest | 1 | 1981 | 407 | 0.030 |
Why?
| | Fatal Outcome | 1 | 1997 | 307 | 0.030 |
Why?
| | Calcium Gluconate | 2 | 1989 | 4 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1986 | 1953 | 0.030 |
Why?
| | Hypertension | 4 | 1987 | 1263 | 0.030 |
Why?
| | Glutethimide | 2 | 1979 | 4 | 0.030 |
Why?
| | Protein Binding | 3 | 2019 | 2273 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 983 | 0.030 |
Why?
| | Ethchlorvynol | 2 | 1979 | 2 | 0.030 |
Why?
| | Heart Rate | 3 | 1993 | 855 | 0.030 |
Why?
| | Kidney Diseases | 2 | 1992 | 427 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2430 | 0.030 |
Why?
| | Central Nervous System | 3 | 1986 | 281 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1886 | 0.030 |
Why?
| | Isonipecotic Acids | 1 | 1974 | 1 | 0.030 |
Why?
| | Clomipramine | 1 | 1974 | 2 | 0.030 |
Why?
| | Dopamine | 2 | 1988 | 283 | 0.030 |
Why?
| | Dibenzazepines | 1 | 1974 | 5 | 0.030 |
Why?
| | Chemistry | 4 | 1985 | 41 | 0.030 |
Why?
| | Chemical Phenomena | 4 | 1985 | 81 | 0.030 |
Why?
| | Central Nervous System Diseases | 2 | 1987 | 74 | 0.030 |
Why?
| | Protein Deficiency | 1 | 1973 | 4 | 0.030 |
Why?
| | Quaternary Ammonium Compounds | 1 | 1974 | 52 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2496 | 0.030 |
Why?
| | Parasympatholytics | 1 | 1973 | 11 | 0.030 |
Why?
| | Georgia (Republic) | 1 | 1993 | 4 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1406 | 0.030 |
Why?
| | Civil Rights | 1 | 1993 | 8 | 0.030 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1973 | 17 | 0.020 |
Why?
| | Gastrointestinal Agents | 1 | 1974 | 66 | 0.020 |
Why?
| | Conversion Disorder | 1 | 1993 | 10 | 0.020 |
Why?
| | Diquat | 1 | 1993 | 1 | 0.020 |
Why?
| | Animals, Domestic | 1 | 2012 | 17 | 0.020 |
Why?
| | Amoxapine | 2 | 1982 | 2 | 0.020 |
Why?
| | Dibenzoxazepines | 2 | 1982 | 2 | 0.020 |
Why?
| | Mercury Poisoning | 2 | 1983 | 6 | 0.020 |
Why?
| | Injections, Intramuscular | 2 | 1986 | 141 | 0.020 |
Why?
| | Dietary Proteins | 1 | 1973 | 136 | 0.020 |
Why?
| | Drug Combinations | 4 | 1993 | 390 | 0.020 |
Why?
| | Treatment Failure | 1 | 1993 | 365 | 0.020 |
Why?
| | Fluorides, Topical | 1 | 1991 | 16 | 0.020 |
Why?
| | Ear Diseases | 1 | 1992 | 18 | 0.020 |
Why?
| | Pregnancy | 6 | 1989 | 7190 | 0.020 |
Why?
| | Accidents | 1 | 1991 | 47 | 0.020 |
Why?
| | Electrocardiography | 4 | 1983 | 662 | 0.020 |
Why?
| | Lactoferrin | 1 | 1991 | 36 | 0.020 |
Why?
| | Transferrin | 1 | 1991 | 50 | 0.020 |
Why?
| | Bicarbonates | 1 | 1991 | 45 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1993 | 541 | 0.020 |
Why?
| | Ferritins | 1 | 1991 | 69 | 0.020 |
Why?
| | Hemoperfusion | 3 | 1979 | 3 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 1990 | 8 | 0.020 |
Why?
| | Administration, Rectal | 1 | 1990 | 13 | 0.020 |
Why?
| | Urography | 1 | 1990 | 19 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1837 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4154 | 0.020 |
Why?
| | Lactation | 1 | 1991 | 192 | 0.020 |
Why?
| | Physicians | 2 | 1993 | 939 | 0.020 |
Why?
| | Dimercaprol | 2 | 1981 | 6 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 1982 | 2310 | 0.020 |
Why?
| | Protective Devices | 1 | 1990 | 29 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 1993 | 422 | 0.020 |
Why?
| | Anticoagulants | 2 | 1989 | 722 | 0.020 |
Why?
| | Creatinine | 1 | 1992 | 506 | 0.020 |
Why?
| | Amyl Nitrite | 1 | 1989 | 1 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4271 | 0.020 |
Why?
| | Ventilators, Mechanical | 1 | 1990 | 70 | 0.020 |
Why?
| | Skin | 4 | 1989 | 755 | 0.020 |
Why?
| | Fetal Death | 1 | 1989 | 58 | 0.020 |
Why?
| | Carboxyhemoglobin | 1 | 1989 | 7 | 0.020 |
Why?
| | Therapeutic Equivalency | 1 | 1989 | 31 | 0.020 |
Why?
| | Apnea | 2 | 1986 | 25 | 0.020 |
Why?
| | Cytochrome-B(5) Reductase | 2 | 1986 | 2 | 0.020 |
Why?
| | Abortion, Spontaneous | 1 | 1989 | 115 | 0.020 |
Why?
| | Congresses as Topic | 1 | 1990 | 221 | 0.020 |
Why?
| | Tablets | 1 | 1988 | 41 | 0.020 |
Why?
| | Information Centers | 1 | 1988 | 2 | 0.020 |
Why?
| | Arsenic | 1 | 1989 | 66 | 0.020 |
Why?
| | Acidosis | 1 | 1989 | 105 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 1993 | 585 | 0.020 |
Why?
| | Tobacco, Smokeless | 1 | 1988 | 13 | 0.020 |
Why?
| | Salicylic Acid | 1 | 1987 | 10 | 0.020 |
Why?
| | Dogs | 2 | 1987 | 437 | 0.020 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1989 | 133 | 0.020 |
Why?
| | Thirst | 1 | 1987 | 4 | 0.020 |
Why?
| | Survival Rate | 1 | 2012 | 2089 | 0.020 |
Why?
| | Pulse | 1 | 1987 | 27 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 1989 | 136 | 0.020 |
Why?
| | Bile | 1 | 1987 | 26 | 0.020 |
Why?
| | Saponins | 1 | 1987 | 11 | 0.020 |
Why?
| | Diagnosis, Differential | 2 | 1987 | 1489 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 2 | 1981 | 169 | 0.020 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 1987 | 11 | 0.020 |
Why?
| | Cysteamine | 2 | 1978 | 7 | 0.020 |
Why?
| | Carrier Proteins | 1 | 1991 | 737 | 0.020 |
Why?
| | Arousal | 1 | 1987 | 157 | 0.020 |
Why?
| | Keratoconjunctivitis | 1 | 1986 | 11 | 0.020 |
Why?
| | Lighting | 1 | 1986 | 30 | 0.020 |
Why?
| | Hemoglobin M | 1 | 1986 | 2 | 0.020 |
Why?
| | Inactivation, Metabolic | 1 | 1986 | 9 | 0.020 |
Why?
| | Abdomen, Acute | 1 | 1986 | 21 | 0.020 |
Why?
| | Methylene Blue | 1 | 1986 | 24 | 0.020 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 1986 | 10 | 0.020 |
Why?
| | Rats | 5 | 1983 | 5597 | 0.020 |
Why?
| | Infant, Premature | 2 | 1981 | 611 | 0.020 |
Why?
| | Ditiocarb | 1 | 1986 | 3 | 0.020 |
Why?
| | Ferrocyanides | 1 | 1986 | 4 | 0.020 |
Why?
| | Aminopropionitrile | 1 | 1986 | 3 | 0.020 |
Why?
| | Kaolin | 1 | 1986 | 5 | 0.010 |
Why?
| | Aluminum Silicates | 1 | 1986 | 16 | 0.010 |
Why?
| | Thioctic Acid | 1 | 1986 | 12 | 0.010 |
Why?
| | Mortality | 1 | 1988 | 375 | 0.010 |
Why?
| | Glycerides | 1 | 1986 | 17 | 0.010 |
Why?
| | Respiratory Tract Diseases | 1 | 1987 | 175 | 0.010 |
Why?
| | Carmustine | 1 | 1986 | 52 | 0.010 |
Why?
| | Antivenins | 1 | 1986 | 29 | 0.010 |
Why?
| | Drug Synergism | 1 | 1987 | 357 | 0.010 |
Why?
| | Dioxins | 1 | 1985 | 7 | 0.010 |
Why?
| | Polychlorinated Dibenzodioxins | 1 | 1985 | 10 | 0.010 |
Why?
| | Documentation | 1 | 1988 | 198 | 0.010 |
Why?
| | Latex | 1 | 1985 | 9 | 0.010 |
Why?
| | Propylene Glycols | 1 | 1985 | 27 | 0.010 |
Why?
| | Triiodothyronine | 1 | 1985 | 54 | 0.010 |
Why?
| | Smoking | 1 | 1993 | 1472 | 0.010 |
Why?
| | Respiration | 1 | 1986 | 206 | 0.010 |
Why?
| | Gastrointestinal Diseases | 1 | 1987 | 216 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1986 | 82 | 0.010 |
Why?
| | Electroencephalography | 1 | 1988 | 532 | 0.010 |
Why?
| | Niacinamide | 1 | 1986 | 86 | 0.010 |
Why?
| | Irritants | 1 | 1985 | 38 | 0.010 |
Why?
| | Turpentine | 1 | 1985 | 5 | 0.010 |
Why?
| | Microcystins | 1 | 1985 | 7 | 0.010 |
Why?
| | Data Collection | 1 | 1988 | 633 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1988 | 1266 | 0.010 |
Why?
| | Ivermectin | 1 | 1985 | 14 | 0.010 |
Why?
| | Brucella | 1 | 1964 | 1 | 0.010 |
Why?
| | Spheroplasts | 1 | 1964 | 1 | 0.010 |
Why?
| | Sleep Stages | 1 | 1985 | 75 | 0.010 |
Why?
| | Biochemical Phenomena | 1 | 1964 | 9 | 0.010 |
Why?
| | Intestines | 1 | 1988 | 358 | 0.010 |
Why?
| | Fluorouracil | 1 | 1986 | 235 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 1993 | 594 | 0.010 |
Why?
| | Bradycardia | 1 | 1985 | 59 | 0.010 |
Why?
| | Tachycardia | 2 | 1987 | 57 | 0.010 |
Why?
| | Tissue Culture Techniques | 1 | 1964 | 83 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 3 | 1976 | 162 | 0.010 |
Why?
| | Solvents | 1 | 1985 | 113 | 0.010 |
Why?
| | Biochemistry | 1 | 1964 | 36 | 0.010 |
Why?
| | Penicillins | 1 | 1964 | 61 | 0.010 |
Why?
| | Arginine | 1 | 1986 | 262 | 0.010 |
Why?
| | Random Allocation | 1 | 1985 | 363 | 0.010 |
Why?
| | Solubility | 1 | 1985 | 242 | 0.010 |
Why?
| | Culture Media | 1 | 1964 | 161 | 0.010 |
Why?
| | Burns, Chemical | 2 | 1981 | 32 | 0.010 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1986 | 182 | 0.010 |
Why?
| | Copper Sulfate | 1 | 1984 | 8 | 0.010 |
Why?
| | Blood Pressure | 2 | 1993 | 1769 | 0.010 |
Why?
| | Chlorpheniramine | 2 | 1974 | 5 | 0.010 |
Why?
| | Biotransformation | 1 | 1984 | 63 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1983 | 41 | 0.010 |
Why?
| | Cytoplasm | 1 | 1964 | 269 | 0.010 |
Why?
| | Drug Packaging | 1 | 1984 | 41 | 0.010 |
Why?
| | Radiography | 2 | 1983 | 844 | 0.010 |
Why?
| | Homeostasis | 1 | 1988 | 640 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 1986 | 388 | 0.010 |
Why?
| | Endotoxins | 1 | 1964 | 221 | 0.010 |
Why?
| | Bilirubin | 1 | 1984 | 97 | 0.010 |
Why?
| | Mercury Compounds | 1 | 1983 | 3 | 0.010 |
Why?
| | Diuresis | 2 | 1980 | 10 | 0.010 |
Why?
| | Doxorubicin | 1 | 1986 | 397 | 0.010 |
Why?
| | Glycine | 1 | 1964 | 187 | 0.010 |
Why?
| | Dextropropoxyphene | 2 | 1980 | 4 | 0.010 |
Why?
| | Mercury | 1 | 1983 | 40 | 0.010 |
Why?
| | Oxides | 1 | 1983 | 51 | 0.010 |
Why?
| | Ephedrine | 1 | 1982 | 4 | 0.010 |
Why?
| | Enema | 1 | 1983 | 46 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1983 | 36 | 0.010 |
Why?
| | Phagocytosis | 1 | 1964 | 299 | 0.010 |
Why?
| | Bacteriophages | 1 | 1964 | 111 | 0.010 |
Why?
| | Powders | 1 | 1982 | 44 | 0.010 |
Why?
| | Cytochromes | 2 | 1973 | 10 | 0.010 |
Why?
| | Inhalation | 1 | 1982 | 29 | 0.010 |
Why?
| | History, 20th Century | 1 | 1984 | 325 | 0.010 |
Why?
| | Cysteine | 1 | 1984 | 210 | 0.010 |
Why?
| | Gagging | 1 | 1982 | 1 | 0.010 |
Why?
| | Caffeine | 1 | 1982 | 74 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1992 | 5408 | 0.010 |
Why?
| | Cattle | 1 | 1985 | 1000 | 0.010 |
Why?
| | Seasons | 1 | 1985 | 556 | 0.010 |
Why?
| | Consciousness | 1 | 1982 | 32 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 1981 | 15 | 0.010 |
Why?
| | Diarrhea | 1 | 1983 | 192 | 0.010 |
Why?
| | Gluconates | 1 | 1981 | 4 | 0.010 |
Why?
| | Reflex | 1 | 1982 | 69 | 0.010 |
Why?
| | Monocytes | 1 | 1964 | 538 | 0.010 |
Why?
| | Carbamazepine | 1 | 1981 | 21 | 0.010 |
Why?
| | Research | 1 | 1964 | 431 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1981 | 79 | 0.010 |
Why?
| | Esophagus | 1 | 1983 | 261 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1981 | 120 | 0.010 |
Why?
| | Selenium | 1 | 1981 | 49 | 0.010 |
Why?
| | Microchemistry | 2 | 1978 | 19 | 0.010 |
Why?
| | Blood Glucose | 1 | 1991 | 2327 | 0.010 |
Why?
| | Polyurethanes | 1 | 1981 | 38 | 0.010 |
Why?
| | Enzyme Activation | 2 | 1973 | 766 | 0.010 |
Why?
| | Gold | 1 | 1981 | 115 | 0.010 |
Why?
| | Formaldehyde | 1 | 1981 | 66 | 0.010 |
Why?
| | Urea | 1 | 1981 | 84 | 0.010 |
Why?
| | Furosemide | 1 | 1980 | 37 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 2000 | 32 | 0.010 |
Why?
| | Methods | 2 | 1977 | 69 | 0.010 |
Why?
| | Nurses | 1 | 1983 | 178 | 0.010 |
Why?
| | Cyclohexanones | 1 | 1979 | 9 | 0.010 |
Why?
| | Oils, Volatile | 1 | 1979 | 6 | 0.010 |
Why?
| | Pharmacists | 1 | 1983 | 240 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 8265 | 0.010 |
Why?
| | Abortifacient Agents | 1 | 1979 | 4 | 0.010 |
Why?
| | Cyclohexanes | 1 | 1979 | 23 | 0.010 |
Why?
| | Metabolism | 1 | 2000 | 44 | 0.010 |
Why?
| | Phenothiazines | 1 | 1979 | 8 | 0.010 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 1979 | 32 | 0.010 |
Why?
| | Calcium | 1 | 1986 | 1183 | 0.010 |
Why?
| | Housing | 1 | 1981 | 144 | 0.010 |
Why?
| | Interprofessional Relations | 1 | 1982 | 281 | 0.010 |
Why?
| | Enuresis | 1 | 1979 | 3 | 0.010 |
Why?
| | Microfilming | 1 | 1979 | 1 | 0.010 |
Why?
| | Down Syndrome | 1 | 1986 | 534 | 0.010 |
Why?
| | Nitrates | 1 | 1979 | 100 | 0.010 |
Why?
| | Gingival Neoplasms | 1 | 1979 | 10 | 0.010 |
Why?
| | Arthritis, Juvenile | 1 | 1979 | 56 | 0.010 |
Why?
| | Self Medication | 1 | 1979 | 12 | 0.010 |
Why?
| | Valproic Acid | 1 | 1979 | 47 | 0.010 |
Why?
| | Thiocyanates | 1 | 1979 | 28 | 0.010 |
Why?
| | Hemostasis | 1 | 1979 | 102 | 0.010 |
Why?
| | Podophyllin | 1 | 1978 | 1 | 0.010 |
Why?
| | Necrosis | 2 | 1979 | 244 | 0.010 |
Why?
| | Pregnancy Trimester, Third | 1 | 1979 | 115 | 0.010 |
Why?
| | Alkaloids | 1 | 1978 | 28 | 0.010 |
Why?
| | Mitral Valve | 1 | 1979 | 96 | 0.010 |
Why?
| | Skin Manifestations | 2 | 1975 | 2 | 0.010 |
Why?
| | Regional Health Planning | 1 | 1978 | 8 | 0.010 |
Why?
| | Magnoliopsida | 1 | 1978 | 34 | 0.010 |
Why?
| | Beverages | 1 | 1978 | 69 | 0.010 |
Why?
| | Methionine | 1 | 1978 | 162 | 0.010 |
Why?
| | Software | 1 | 1983 | 690 | 0.010 |
Why?
| | Opioid-Related Disorders | 1 | 1985 | 600 | 0.010 |
Why?
| | Heart Valve Prosthesis | 1 | 1979 | 134 | 0.010 |
Why?
| | Clonazepam | 1 | 1977 | 4 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 1976 | 85 | 0.010 |
Why?
| | Spectrophotometry | 2 | 1976 | 61 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1977 | 18 | 0.010 |
Why?
| | Transportation of Patients | 1 | 1978 | 68 | 0.010 |
Why?
| | Citrus | 1 | 1977 | 7 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1987 | 4557 | 0.010 |
Why?
| | Acetates | 1 | 1977 | 80 | 0.010 |
Why?
| | Hypersensitivity | 1 | 1979 | 252 | 0.010 |
Why?
| | Fetal Blood | 1 | 1979 | 342 | 0.010 |
Why?
| | Models, Chemical | 3 | 1985 | 269 | 0.010 |
Why?
| | Oils | 1 | 1976 | 22 | 0.010 |
Why?
| | Milk | 1 | 1977 | 119 | 0.010 |
Why?
| | Patient Compliance | 1 | 2000 | 588 | 0.010 |
Why?
| | Kidney Papillary Necrosis | 1 | 1975 | 1 | 0.010 |
Why?
| | Pericarditis | 1 | 1975 | 11 | 0.010 |
Why?
| | Agranulocytosis | 1 | 1975 | 30 | 0.010 |
Why?
| | Athetosis | 1 | 1974 | 7 | 0.010 |
Why?
| | Chorea | 1 | 1974 | 13 | 0.010 |
Why?
| | Myoclonus | 1 | 1974 | 17 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1987 | 2168 | 0.010 |
Why?
| | Levallorphan | 1 | 1974 | 1 | 0.010 |
Why?
| | Nalorphine | 1 | 1974 | 1 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 1987 | 6048 | 0.010 |
Why?
| | Health Education | 1 | 1978 | 358 | 0.010 |
Why?
| | Heart Block | 1 | 1974 | 40 | 0.010 |
Why?
| | Nitrosourea Compounds | 1 | 1973 | 1 | 0.010 |
Why?
| | Cytochrome Reductases | 1 | 1973 | 3 | 0.010 |
Why?
| | Flavin Mononucleotide | 1 | 1973 | 8 | 0.010 |
Why?
| | Histamine H1 Antagonists | 1 | 1973 | 24 | 0.010 |
Why?
| | Binding Sites | 2 | 1976 | 1329 | 0.010 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 1973 | 17 | 0.010 |
Why?
| | Haplorhini | 1 | 1973 | 52 | 0.010 |
Why?
| | Riboflavin | 1 | 1973 | 15 | 0.010 |
Why?
| | Hyperkalemia | 1 | 1974 | 35 | 0.010 |
Why?
| | Macaca | 1 | 1973 | 65 | 0.010 |
Why?
| | Potassium | 1 | 1974 | 152 | 0.010 |
Why?
| | Temperature | 1 | 1977 | 679 | 0.010 |
Why?
| | Mixed Function Oxygenases | 1 | 1973 | 49 | 0.010 |
Why?
| | Water | 1 | 1977 | 469 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1973 | 131 | 0.010 |
Why?
| | Drug Tolerance | 1 | 1973 | 100 | 0.010 |
Why?
| | Heme | 1 | 1973 | 89 | 0.010 |
Why?
| | Methyltransferases | 1 | 1973 | 74 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1973 | 119 | 0.010 |
Why?
| | Antidepressive Agents | 1 | 1974 | 248 | 0.010 |
Why?
| | Organ Size | 1 | 1973 | 463 | 0.010 |
Why?
| | Phospholipids | 1 | 1973 | 213 | 0.010 |
Why?
| | NADP | 1 | 1971 | 55 | 0.010 |
Why?
| | Plants | 1 | 1973 | 226 | 0.010 |
Why?
| | Pre-Eclampsia | 1 | 1973 | 204 | 0.010 |
Why?
| | Chickenpox | 1 | 1972 | 81 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1981 | 1158 | 0.010 |
Why?
| | Safety | 1 | 1993 | 356 | 0.010 |
Why?
| | Hypoglycemia | 1 | 1975 | 477 | 0.000 |
Why?
| | Suicide | 2 | 1976 | 720 | 0.000 |
Why?
| | Glioblastoma | 1 | 1973 | 353 | 0.000 |
Why?
| | Body Weight | 1 | 1973 | 976 | 0.000 |
Why?
| | Pulmonary Edema | 2 | 1981 | 106 | 0.000 |
Why?
| | Herpes Zoster | 1 | 1972 | 315 | 0.000 |
Why?
| | Hyperkinesis | 1 | 1987 | 16 | 0.000 |
Why?
| | Brain Neoplasms | 2 | 1973 | 1318 | 0.000 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 1984 | 20 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1964 | 159 | 0.000 |
Why?
| | Soft Tissue Neoplasms | 1 | 1985 | 127 | 0.000 |
Why?
| | Virulence | 1 | 1964 | 278 | 0.000 |
Why?
| | Structure-Activity Relationship | 1 | 1984 | 570 | 0.000 |
Why?
| | Foreign-Body Migration | 1 | 1983 | 32 | 0.000 |
Why?
| | Sarcoma | 1 | 1985 | 205 | 0.000 |
Why?
| | Neuromuscular Diseases | 1 | 1984 | 146 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1973 | 2194 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1981 | 321 | 0.000 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1981 | 194 | 0.000 |
Why?
| | Infant, Low Birth Weight | 1 | 1981 | 153 | 0.000 |
Why?
| | Health Occupations | 1 | 1980 | 36 | 0.000 |
Why?
| | Respiration Disorders | 1 | 1981 | 77 | 0.000 |
Why?
| | Skin Absorption | 1 | 1979 | 13 | 0.000 |
Why?
| | Biological Availability | 1 | 1980 | 142 | 0.000 |
Why?
| | Medicine, Traditional | 1 | 1979 | 23 | 0.000 |
Why?
| | Accidents, Occupational | 1 | 1979 | 18 | 0.000 |
Why?
| | Fires | 1 | 1981 | 87 | 0.000 |
Why?
| | Electric Stimulation Therapy | 1 | 1979 | 62 | 0.000 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1979 | 142 | 0.000 |
Why?
| | Podophyllotoxin | 1 | 1978 | 8 | 0.000 |
Why?
| | Condylomata Acuminata | 1 | 1978 | 7 | 0.000 |
Why?
| | Vulvar Neoplasms | 1 | 1978 | 13 | 0.000 |
Why?
| | Shock | 1 | 1979 | 108 | 0.000 |
Why?
| | Heart | 1 | 1982 | 636 | 0.000 |
Why?
| | Pacemaker, Artificial | 1 | 1979 | 126 | 0.000 |
Why?
| | Administration, Topical | 1 | 1978 | 150 | 0.000 |
Why?
| | Gestational Age | 1 | 1981 | 975 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1976 | 3 | 0.000 |
Why?
| | Renal Dialysis | 1 | 1981 | 462 | 0.000 |
Why?
| | Carbon Radioisotopes | 1 | 1976 | 29 | 0.000 |
Why?
| | Vision Disorders | 1 | 1978 | 178 | 0.000 |
Why?
| | Neoplasms | 1 | 1972 | 2875 | 0.000 |
Why?
| | Mathematics | 1 | 1976 | 100 | 0.000 |
Why?
| | Isotope Labeling | 1 | 1976 | 82 | 0.000 |
Why?
| | Quality of Health Care | 1 | 1980 | 691 | 0.000 |
Why?
| | Referral and Consultation | 1 | 1980 | 851 | 0.000 |
Why?
| | Blood Platelet Disorders | 1 | 1973 | 10 | 0.000 |
Why?
| | Remission, Spontaneous | 1 | 1973 | 40 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1973 | 112 | 0.000 |
Why?
| | Recurrence | 1 | 1977 | 1135 | 0.000 |
Why?
| | Astrocytoma | 1 | 1973 | 129 | 0.000 |
Why?
| | Dinitrophenols | 1 | 1972 | 7 | 0.000 |
Why?
| | Complement Fixation Tests | 1 | 1972 | 5 | 0.000 |
Why?
| | Immune Sera | 1 | 1972 | 77 | 0.000 |
Why?
| | Splenectomy | 1 | 1972 | 65 | 0.000 |
Why?
| | Ependymoma | 1 | 1973 | 176 | 0.000 |
Why?
| | Medulloblastoma | 1 | 1973 | 215 | 0.000 |
Why?
| | Neoplasm Metastasis | 1 | 1973 | 688 | 0.000 |
Why?
| | Lymphoma | 1 | 1972 | 232 | 0.000 |
Why?
| | Blood Platelets | 1 | 1973 | 400 | 0.000 |
Why?
| | Hodgkin Disease | 1 | 1972 | 171 | 0.000 |
Why?
| | Leukemia | 1 | 1972 | 245 | 0.000 |
Why?
| | Herpesvirus 3, Human | 1 | 1972 | 336 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1972 | 388 | 0.000 |
Why?
| | Chronic Disease | 1 | 1973 | 1813 | 0.000 |
Why?
|
|
Rumack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|